Apyx Medical Corp 10QSB, filed Aug 9, 2006: Officer certification (Section 906)
BOVIE
MEDICAL CORPORATION
EXHIBIT
32.1
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In
connection with the Quarterly Report of Bovie Medical Corporation (the
“Company”) on Form 10-QSB for the year ended June 30, 2006 as filed with the
Securities and Exchange Commission on the date hereof, I, Andrew Makrides,
President and Chairman of the Board of the Company, certify, pursuant to 18
USC
§1350 as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002,
that
(1) the quarterly report fully complies with the requirements of section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and (2) the information
contained in the annual report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
Date:
August 9, 2006
|
|
/s/
Andrew Makrides
|
|
|
President,
Chief
|
|
|
Executive
Officer, Chairman
|
|
|
of
the Board and Director
|
A
signed
original of this written statement required by Section 906 of the Sarbanes-Oxley
Act has been provided to the Company and will be retained by the Company and
furnished to the Securities and Exchange Commission or its staff upon
request.
BOVIE
MEDICAL CORPORATION
EXHIBIT
32.2
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In
connection with the Quarterly Report of Bovie Medical Corporation (the
“Company”) on Form 10-QSB for the year ended June 30, 2006 as filed with the
Securities and Exchange Commission on the date hereof, I, Andrew Makrides,
Chief
Financial Officer, certify, pursuant to 18 USC §1350 as adopted pursuant to
section 906 of the Sarbanes-Oxley Act of 2002, that (1) the Annual Report fully
complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and (2) the information contained in the quarterly report
fairly presents, in all material respects, the financial condition and results
of operations of the Company.
Date:
August 9, 2005
|
|
/s/
Andrew Makrides
|
|
|
Chief
Financial Officer,
|
A
signed
original of this written statement required by Section 906 of the Sarbanes-Oxley
Act has been provided to the Company and will be retained by the Company and
furnished to the Securities and Exchange Commission or its staff upon
request.